-+ 0.00%
-+ 0.00%
-+ 0.00%

AstraZeneca Isn't Buying Summit Therapeutics. Its $2 Billion Investment Might Be Even Better.

Barron‘s·09/29/2026 12:13:00

請登錄查看新聞詳情